FDA Adverse Event Malfunction Summary report: N

COMBUR10 TEST M

MDR report key: 14083155 · Received April 12, 2022

Report

Report Number
1823260-2022-01001
Event Type
Malfunction
Date Received
April 12, 2022
Date of Event
March 16, 2022
Report Date
May 2, 2022
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LJX
PMA / PMN Number
K032437
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

FOR PATIENT 1, A BACTERIOGRAM WAS PERFORMED AND GRAM POSITIVE COCCI BACTERIUM WAS IDENTIFIED BUT IT DID NOT GROW IN CYSTEINE-LACTOSE-ELECTROLYTE-DEFICIENT (CLED) AGAR. THE TEST STRIPS WERE REQUESTED FOR INVESTIGATION. HOWEVER; THE PRODUCT IS NOT EXPECTED FOR RETURN. THE RETENTION MATERIAL OF LOT 55017400 WAS MEASURED ON A URISYS 1100 ANALYZER AT THE INVESTIGATION SITE WITH 0-NATIVE-URINE AND A LEUKOCYTES-DILUTION-SERIES. NEITHER FALSE POSITIVE NOR FALSE NEGATIVE RESULTS WERE OBSERVED. THE RETENTION MATERIAL FULFILLS THE REQUIREMENTS. THE INVESTIGATION IS ONGOING.

Additional Manufacturer Narrative · 0

THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.

Description of Event or Problem · 0

THE INITIAL REPORTER COMPLAINED OF QUESTIONABLE NEGATIVE RESULTS FOR 2 PATIENTS TESTED FOR LEUKOCYTES WITH COMBUR10 TEST M URINE TEST STRIPS ON A URISYS 1100 INSTRUMENT. PATIENT 1 INITIAL RESULT WAS NEGATIVE. THE 2ND RESULT WAS 500 LEU/UL. PATIENT 2 INITIAL RESULT WAS NEGATIVE. THE 2ND RESULT WAS 100 LEU/UL. NO QUESTIONABLE RESULTS WERE REPORTED OUTSIDE OF THE LABORATORY. THE HIGHER RESULTS WERE BELIEVED TO BE CORRECT. THE URISYS 1100 INSTRUMENT SERIAL NUMBER WAS (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
209434 COMBUR10 TEST M METHOD, ENZYMATIC, GLUCOSE (URINARY, NON-QUANTITATIVE) LJX ROCHE DIAGNOSTICS NA 55017404

Patients

Seq Age Sex Outcome Treatment
1 5 YR Female PATIENT 2 ¿ EMPAGLIFLOZIN| PATIENT 2 ¿ METFORMIN HYDROCHLORIDE